IFNG and neoplasm: Compared to tumor-bearing mice that received CAR-T cells only, all EC17 treated tumor cohorts had ~30x (day 11) and ~10x (day 12) higher IFNγ production in mouse plasma, and the levels of this cytokine decreased naturally from 20 to 42 h later (Figure 6B).